A Phase II Trial of Capecitabine Rapidly Disintegrating Tablets and Concomitant Radiation Therapy in Children With Newly Diagnosed Brainstem Gliomas

Trial Profile

A Phase II Trial of Capecitabine Rapidly Disintegrating Tablets and Concomitant Radiation Therapy in Children With Newly Diagnosed Brainstem Gliomas

Completed
Phase of Trial: Phase II

Latest Information Update: 23 Jul 2016

At a glance

  • Drugs Capecitabine (Primary)
  • Indications Glioma
  • Focus Therapeutic Use
  • Sponsors Roche
  • Most Recent Events

    • 05 Feb 2014 According to ClinicalTrial.gov record, status changed from active, no longer recruiting to completed.
    • 02 Dec 2013 Planned end date changed from 1 Jun 2013 to 1 Dec 2013 as reported by ClinicalTrials.gov.
    • 15 Nov 2012 Planned end date changed from 1 Jun 2015 to 1 Jun 2013 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top